Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients

Updated: Sep 28, 2018

Irene Ghobrial, MD of Dana-Farber Cancer Institute, Boston, MA, discusses the benefits of early therapeutic interventions for patients with high-risk smouldering multiple myeloma (MM). +watch video

DFCI Logo Lens Stacked PNG_edited.png
CPOP_R02.png

© 2018 Dana-Farber Cancer Institute |  Terms of Use  |   Privacy Policy